Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Feb 23;160(4):513–525.

Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity

J D Douketis 1, J W Feightner 1, J Attia 1, W F Feldman 1
PMCID: PMC1230077  PMID: 10081468

Abstract

OBJECTIVES: (1) To evaluate the evidence relating to the effectiveness of methods to prevent and treat obesity, and (2) to provide recommendations for the prevention and treatment of obesity in adults aged 18 to 65 years and for the measurement of the body mass index (BMI) as part of a periodic health examination. OPTIONS: In adults with obesity (BMI greater than 27) management options include weight reduction, prevention of further weight gain or no intervention. OUTCOMES: The long-term (more than 2 years) effectiveness of (a) methods to prevent obesity and (b) methods to treat obesity. EVIDENCE: MEDLINE was searched for articles published from 1966 to April 1998 that related to the prevention and treatment of obesity; additional articles were identified from the bibliographies of review articles and the listings of Current Contents. Selection criteria were used to limit the analysis to prospective studies with at least 2 years' follow-up. BENEFITS, HARM AND COSTS: Health benefits of weight reduction were evaluated in terms of alleviation of symptoms, improved management of obesity-related diseases and a reduction in major clinical outcomes. The health risk of weight-reduction methods were briefly evaluated in terms of increased mortality and morbidity. VALUES: The recommendations of this report reflect the commitment of the Canadian Task Force on Preventive Health Care to provide a structured, evidence-based appraisal of whether a manoeuvre should be part of a periodic health examination. RECOMMENDATIONS: (1) Prevention: There is insufficient evidence to recommend in favour of or against community-based obesity prevention programs; however, because of considerable health risks associated with obesity and the limited long-term effectiveness of weight-reduction methods, the prevention of obesity should be a high priority for health care providers (grade C recommendation). (2) Treatment: (a) For obese adults without obesity-related diseases, there is insufficient evidence to recommend in favour of or against weight-reduction therapy because of a lack of evidence supporting the long-term effectiveness of weight-reduction methods (grade C recommendation); (b) for obese adults with obesity-related diseases (e.g., diabetes mellitus, hypertension), weight reduction is recommended because it can alleviate symptoms and reduce drug therapy requirements, at least in the short term (grade B recommendation). (3) Detection: (a) for people without obesity-related diseases, there is insufficient evidence to recommend the inclusion or exclusion of BMI measurement as part of a periodic health examination, and therefore BMI measurement is left to the discretion of individual health care providers (grade C recommendation); (b) for people with obesity-related diseases, BMI measurement is recommended because weight reduction should be considered with a BMI of more than 27 (grade B recommendation). VALIDATION: The findings of this analysis were reviewed through an iterative process by the members of the Canadian Task Force on Preventive Health Care. SPONSORS: The Canadian Task Force on Preventive Health Care is funded through a partnership between the Provincial and Territorial Ministries of Health and Health Canada.

Full Text

The Full Text of this article is available as a PDF (170.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., Higenbottam T., Oakley C., Wouters E., Aubier M. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996 Aug 29;335(9):609–616. doi: 10.1056/NEJM199608293350901. [DOI] [PubMed] [Google Scholar]
  2. Adams S. O., Grady K. E., Lund A. K., Mukaida C., Wolk C. H. Weight loss: long-term results in an ambulatory setting. J Am Diet Assoc. 1983 Sep;83(3):306–310. [PubMed] [Google Scholar]
  3. Andersen T., Stokholm K. H., Backer O. G., Quaade F. Long-term (5-year) results after either horizontal gastroplasty or very-low-calorie diet for morbid obesity. Int J Obes. 1988;12(4):277–284. [PubMed] [Google Scholar]
  4. Anderson J. W., Brinkman V. L., Hamilton C. C. Weight loss and 2-y follow-up for 80 morbidly obese patients treated with intensive very-low-calorie diet and an education program. Am J Clin Nutr. 1992 Jul;56(1 Suppl):244S–246S. doi: 10.1093/ajcn/56.1.244S. [DOI] [PubMed] [Google Scholar]
  5. Anderson J. W., Hamilton C. C., Crown-Weber E., Riddlemoser M., Gustafson N. J. Safety and effectiveness of a multidisciplinary very-low-calorie diet program for selected obese individuals. J Am Diet Assoc. 1991 Dec;91(12):1582–1584. [PubMed] [Google Scholar]
  6. Ashley S., Bird D. L., Sugden G., Royston C. M. Vertical banded gastroplasty for the treatment of morbid obesity. Br J Surg. 1993 Nov;80(11):1421–1423. doi: 10.1002/bjs.1800801122. [DOI] [PubMed] [Google Scholar]
  7. Ashwell M., Lejeune S., McPherson K. Ratio of waist circumference to height may be better indicator of need for weight management. BMJ. 1996 Feb 10;312(7027):377–377. doi: 10.1136/bmj.312.7027.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Benjamin S. B., Maher K. A., Cattau E. L., Jr, Collen M. J., Fleischer D. E., Lewis J. H., Ciarleglio C. A., Earll J. M., Schaffer S., Mirkin K. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity. Gastroenterology. 1988 Sep;95(3):581–588. doi: 10.1016/s0016-5085(88)80001-5. [DOI] [PubMed] [Google Scholar]
  9. Björntorp P. Obesity. Lancet. 1997 Aug 9;350(9075):423–426. doi: 10.1016/S0140-6736(97)04503-0. [DOI] [PubMed] [Google Scholar]
  10. Björvell H., Rössner S. A ten-year follow-up of weight change in severely obese subjects treated in a combined behavioural modification programme. Int J Obes Relat Metab Disord. 1992 Aug;16(8):623–625. [PubMed] [Google Scholar]
  11. Bray G. A., Greenway F. L., Molitch M. E., Dahms W. T., Atkinson R. L., Hamilton K. Use of anthropometric measures to assess weight loss. Am J Clin Nutr. 1978 May;31(5):769–773. doi: 10.1093/ajcn/31.5.769. [DOI] [PubMed] [Google Scholar]
  12. Bray G. A. Obesity: basic considerations and clinical approaches. Dis Mon. 1989 Jul;35(7):449–537. doi: 10.1016/0011-5029(89)90007-2. [DOI] [PubMed] [Google Scholar]
  13. Chan J. M., Rimm E. B., Colditz G. A., Stampfer M. J., Willett W. C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994 Sep;17(9):961–969. doi: 10.2337/diacare.17.9.961. [DOI] [PubMed] [Google Scholar]
  14. Colditz G. A., Willett W. C., Rotnitzky A., Manson J. E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995 Apr 1;122(7):481–486. doi: 10.7326/0003-4819-122-7-199504010-00001. [DOI] [PubMed] [Google Scholar]
  15. Connolly H. M., Crary J. L., McGoon M. D., Hensrud D. D., Edwards B. S., Edwards W. D., Schaff H. V. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28;337(9):581–588. doi: 10.1056/NEJM199708283370901. [DOI] [PubMed] [Google Scholar]
  16. Dattilo A. M., Kris-Etherton P. M. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992 Aug;56(2):320–328. doi: 10.1093/ajcn/56.2.320. [DOI] [PubMed] [Google Scholar]
  17. Davis B. R., Blaufox M. D., Oberman A., Wassertheil-Smoller S., Zimbaldi N., Cutler J. A., Kirchner K., Langford H. G. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med. 1993 Aug 9;153(15):1773–1782. doi: 10.1001/archinte.153.15.1773. [DOI] [PubMed] [Google Scholar]
  18. Drent M. L., Larsson I., William-Olsson T., Quaade F., Czubayko F., von Bergmann K., Strobel W., Sjöström L., van der Veen E. A. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord. 1995 Apr;19(4):221–226. [PubMed] [Google Scholar]
  19. Ducimetiere P., Richard J., Cambien F. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes. 1986;10(3):229–240. [PubMed] [Google Scholar]
  20. Elmer P. J., Grimm R., Jr, Laing B., Grandits G., Svendsen K., Van Heel N., Betz E., Raines J., Link M., Stamler J. Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med. 1995 Jul;24(4):378–388. doi: 10.1006/pmed.1995.1062. [DOI] [PubMed] [Google Scholar]
  21. Enzi G., Baritussio A., Marchiori E., Crepaldi G. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity. J Int Med Res. 1976;4(5):305–318. doi: 10.1177/030006057600400504. [DOI] [PubMed] [Google Scholar]
  22. Eriksson K. F., Lindgärde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991 Dec;34(12):891–898. doi: 10.1007/BF00400196. [DOI] [PubMed] [Google Scholar]
  23. Everhart J. E. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993 Nov 15;119(10):1029–1035. doi: 10.7326/0003-4819-119-10-199311150-00010. [DOI] [PubMed] [Google Scholar]
  24. Fitz J. D., Sperling E. M., Fein H. G. A hypocaloric high-protein diet as primary therapy for adults with obesity-related diabetes: effective long-term use in a community hospital. Diabetes Care. 1983 Jul-Aug;6(4):328–333. doi: 10.2337/diacare.6.4.328. [DOI] [PubMed] [Google Scholar]
  25. Florey C. du V. The use and interpretation of ponderal index and other weight-height ratios in epidemiological studies. J Chronic Dis. 1970 Aug;23(2):93–103. doi: 10.1016/0021-9681(70)90068-8. [DOI] [PubMed] [Google Scholar]
  26. Fortmann S. P., Williams P. T., Hulley S. B., Haskell W. L., Farquhar J. W. Effect of health education on dietary behavior: the Stanford Three Community Study. Am J Clin Nutr. 1981 Oct;34(10):2030–2038. doi: 10.1093/ajcn/34.10.2030. [DOI] [PubMed] [Google Scholar]
  27. Freedman D. S., Jacobsen S. J., Barboriak J. J., Sobocinski K. A., Anderson A. J., Kissebah A. H., Sasse E. A., Gruchow H. W. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation. 1990 May;81(5):1498–1506. doi: 10.1161/01.cir.81.5.1498. [DOI] [PubMed] [Google Scholar]
  28. Garrow J. S., Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes. 1985;9(2):147–153. [PubMed] [Google Scholar]
  29. Goldbloom R., Battista R. N. The periodic health examination: 1. Introduction. CMAJ. 1986 Apr 1;134(7):721–723. [PMC free article] [PubMed] [Google Scholar]
  30. Goldstein D. J., Rampey A. H., Jr, Enas G. G., Potvin J. H., Fludzinski L. A., Levine L. R. Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord. 1994 Mar;18(3):129–135. [PubMed] [Google Scholar]
  31. Guy-Grand B., Apfelbaum M., Crepaldi G., Gries A., Lefebvre P., Turner P. International trial of long-term dexfenfluramine in obesity. Lancet. 1989 Nov 11;2(8672):1142–1145. doi: 10.1016/s0140-6736(89)91499-2. [DOI] [PubMed] [Google Scholar]
  32. Hakala P., Karvetti R. L., Rönnemaa T. Group vs. individual weight reduction programmes in the treatment of severe obesity--a five year follow-up study. Int J Obes Relat Metab Disord. 1993 Feb;17(2):97–102. [PubMed] [Google Scholar]
  33. Hakala P. Weight reduction programmes at a rehabilitation centre and a health centre based on group counselling and individual support: short- and long-term follow-up study. Int J Obes Relat Metab Disord. 1994 Jul;18(7):483–489. [PubMed] [Google Scholar]
  34. Hall J. C., Watts J. M., O'Brien P. E., Dunstan R. E., Walsh J. F., Slavotinek A. H., Elmslie R. G. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg. 1990 Apr;211(4):419–427. doi: 10.1097/00000658-199004000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hamm P., Shekelle R. B., Stamler J. Large fluctuations in body weight during young adulthood and twenty-five-year risk of coronary death in men. Am J Epidemiol. 1989 Feb;129(2):312–318. doi: 10.1093/oxfordjournals.aje.a115135. [DOI] [PubMed] [Google Scholar]
  36. Harris T. B., Launer L. J., Madans J., Feldman J. J. Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. BMJ. 1997 Jun 21;314(7097):1791–1794. doi: 10.1136/bmj.314.7097.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Haskell W. L., Alderman E. L., Fair J. M., Maron D. J., Mackey S. F., Superko H. R., Williams P. T., Johnstone I. M., Champagne M. A., Krauss R. M. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994 Mar;89(3):975–990. doi: 10.1161/01.cir.89.3.975. [DOI] [PubMed] [Google Scholar]
  38. Heymsfield S. B., Casper K. Anthropometric assessment of the adult hospitalized patient. JPEN J Parenter Enteral Nutr. 1987 Sep-Oct;11(5 Suppl):36S–41S. doi: 10.1177/014860718701100503. [DOI] [PubMed] [Google Scholar]
  39. Hubert H. B., Feinleib M., McNamara P. M., Castelli W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983 May;67(5):968–977. doi: 10.1161/01.cir.67.5.968. [DOI] [PubMed] [Google Scholar]
  40. Jalkanen L. The effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health care. Scand J Soc Med. 1991 Mar;19(1):66–71. doi: 10.1177/140349489101900112. [DOI] [PubMed] [Google Scholar]
  41. Jarrett R. J., Shipley M. J., Rose G. Weight and mortality in the Whitehall Study. Br Med J (Clin Res Ed) 1982 Aug 21;285(6341):535–537. doi: 10.1136/bmj.285.6341.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jeffery R. W., Bjornson-Benson W. M., Rosenthal B. S., Lindquist R. A., Kurth C. L., Johnson S. L. Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men. Prev Med. 1984 Mar;13(2):155–168. doi: 10.1016/0091-7435(84)90048-3. [DOI] [PubMed] [Google Scholar]
  43. Jeffery R. W. Does weight cycling present a health risk? Am J Clin Nutr. 1996 Mar;63(3 Suppl):452S–455S. doi: 10.1093/ajcn/63.3.452. [DOI] [PubMed] [Google Scholar]
  44. Jeffery R. W. Minnesota studies on community-based approaches to weight loss and control. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):719–721. doi: 10.7326/0003-4819-119-7_Part_2-199310011-00018. [DOI] [PubMed] [Google Scholar]
  45. Kannel W. B., Cupples L. A., Ramaswami R., Stokes J., 3rd, Kreger B. E., Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol. 1991;44(2):183–190. doi: 10.1016/0895-4356(91)90265-b. [DOI] [PubMed] [Google Scholar]
  46. Karvetti R. L., Hakala P. A seven-year follow-up of a weight reduction programme in Finnish primary health care. Eur J Clin Nutr. 1992 Oct;46(10):743–752. [PubMed] [Google Scholar]
  47. Kelsey J. L., LiVolsi V. A., Holford T. R., Fischer D. B., Mostow E. D., Schwartz P. E., O'Connor T., White C. A case-control study of cancer of the endometrium. Am J Epidemiol. 1982 Aug;116(2):333–342. doi: 10.1093/oxfordjournals.aje.a113417. [DOI] [PubMed] [Google Scholar]
  48. Keys A., Fidanza F., Karvonen M. J., Kimura N., Taylor H. L. Indices of relative weight and obesity. J Chronic Dis. 1972 Jul 1;25(6):329–343. doi: 10.1016/0021-9681(72)90027-6. [DOI] [PubMed] [Google Scholar]
  49. King A. C., Frey-Hewitt B., Dreon D. M., Wood P. D. Diet vs exercise in weight maintenance. The effects of minimal intervention strategies on long-term outcomes in men. Arch Intern Med. 1989 Dec;149(12):2741–2746. doi: 10.1001/archinte.149.12.2741. [DOI] [PubMed] [Google Scholar]
  50. King A. C., Tribble D. L. The role of exercise in weight regulation in nonathletes. Sports Med. 1991 May;11(5):331–349. doi: 10.2165/00007256-199111050-00004. [DOI] [PubMed] [Google Scholar]
  51. Kirschner M. A., Schneider G., Ertel N. H., Gorman J. An eight-year experience with a very-low-calorie formula diet for control of major obesity. Int J Obes. 1988;12(1):69–80. [PubMed] [Google Scholar]
  52. Kramer F. M., Jeffery R. W., Forster J. L., Snell M. K. Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women. Int J Obes. 1989;13(2):123–136. [PubMed] [Google Scholar]
  53. Langford H. G., Blaufox M. D., Oberman A., Hawkins C. M., Curb J. D., Cutter G. R., Wassertheil-Smoller S., Pressel S., Babcock C., Abernethy J. D. Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA. 1985 Feb 1;253(5):657–664. [PubMed] [Google Scholar]
  54. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1257–1261. doi: 10.1136/bmj.289.6454.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lean M. E., Powrie J. K., Anderson A. S., Garthwaite P. H. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med. 1990 Mar-Apr;7(3):228–233. doi: 10.1111/j.1464-5491.1990.tb01375.x. [DOI] [PubMed] [Google Scholar]
  56. Lechner G. W., Elliott D. W. Comparison of weight loss after gastric exclusion and partitioning. Arch Surg. 1983 Jun;118(6):685–692. doi: 10.1001/archsurg.1983.01390060007002. [DOI] [PubMed] [Google Scholar]
  57. Ledoux M., Lambert J., Reeder B. A., Després J. P. A comparative analysis of weight to height and waist to hip circumference indices as indicators of the presence of cardiovascular disease risk factors. Canadian Heart Health Surveys Research Group. CMAJ. 1997 Jul 1;157 (Suppl 1):S32–S38. [PubMed] [Google Scholar]
  58. Lindor K. D., Hughes R. W., Jr, Ilstrup D. M., Jensen M. D. Intragastric balloons in comparison with standard therapy for obesity--a randomized, double-blind trial. Mayo Clin Proc. 1987 Nov;62(11):992–996. doi: 10.1016/s0025-6196(12)65069-1. [DOI] [PubMed] [Google Scholar]
  59. Lissner L., Odell P. M., D'Agostino R. B., Stokes J., 3rd, Kreger B. E., Belanger A. J., Brownell K. D. Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 1991 Jun 27;324(26):1839–1844. doi: 10.1056/NEJM199106273242602. [DOI] [PubMed] [Google Scholar]
  60. Loube D. I., Loube A. A., Mitler M. M. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc. 1994 Nov;94(11):1291–1295. doi: 10.1016/0002-8223(94)92462-7. [DOI] [PubMed] [Google Scholar]
  61. Lubin F., Ruder A. M., Wax Y., Modan B. Overweight and changes in weight throughout adult life in breast cancer etiology. A case-control study. Am J Epidemiol. 1985 Oct;122(4):579–588. doi: 10.1093/oxfordjournals.aje.a114137. [DOI] [PubMed] [Google Scholar]
  62. MacLean L. D., Rhode B. M., Forse R. A. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery. 1990 Jan;107(1):20–27. [PubMed] [Google Scholar]
  63. Manning R. M., Jung R. T., Leese G. P., Newton R. W. The comparison of four weight reduction strategies aimed at overweight diabetic patients. Diabet Med. 1995 May;12(5):409–415. doi: 10.1111/j.1464-5491.1995.tb00504.x. [DOI] [PubMed] [Google Scholar]
  64. Manson J. E., Nathan D. M., Krolewski A. S., Stampfer M. J., Willett W. C., Hennekens C. H. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA. 1992 Jul 1;268(1):63–67. [PubMed] [Google Scholar]
  65. Manson J. E., Willett W. C., Stampfer M. J., Colditz G. A., Hunter D. J., Hankinson S. E., Hennekens C. H., Speizer F. E. Body weight and mortality among women. N Engl J Med. 1995 Sep 14;333(11):677–685. doi: 10.1056/NEJM199509143331101. [DOI] [PubMed] [Google Scholar]
  66. Mathus-Vliegen E. M., van de Voorde K., Kok A. M., Res A. M. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour. J Intern Med. 1992 Aug;232(2):119–127. doi: 10.1111/j.1365-2796.1992.tb00560.x. [DOI] [PubMed] [Google Scholar]
  67. Miura J., Arai K., Tsukahara S., Ohno M., Ikeda Y. The long term effectiveness of combined therapy by behavior modification and very low calorie diet: 2 years follow-up. Int J Obes. 1989;13 (Suppl 2):73–77. [PubMed] [Google Scholar]
  68. Muls E., Kempen K., Vansant G., Saris W. Is weight cycling detrimental to health? A review of the literature in humans. Int J Obes Relat Metab Disord. 1995 Sep;19 (Suppl 3):S46–S50. [PubMed] [Google Scholar]
  69. Niebauer J., Hambrecht R., Velich T., Hauer K., Marburger C., Kälberer B., Weiss C., von Hodenberg E., Schlierf G., Schuler G. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation. 1997 Oct 21;96(8):2534–2541. doi: 10.1161/01.cir.96.8.2534. [DOI] [PubMed] [Google Scholar]
  70. Nomura A., Heilbrun L. K., Stemmermann G. N. Body mass index as a predictor of cancer in men. J Natl Cancer Inst. 1985 Feb;74(2):319–323. [PubMed] [Google Scholar]
  71. Nunn R. G., Newton K. S., Faucher P. 2.5 years follow-up of weight and Body Mass Index values in the Weight Control for Life! program: a descriptive analysis. Addict Behav. 1992 Nov-Dec;17(6):579–585. doi: 10.1016/0306-4603(92)90067-6. [DOI] [PubMed] [Google Scholar]
  72. Näslund I., Wickbom G., Christoffersson E., Agren G. A prospective randomized comparison of gastric bypass and gastroplasty. Complications and early results. Acta Chir Scand. 1986 Nov;152:681–689. [PubMed] [Google Scholar]
  73. O'Connor H. T., Richman R. M., Steinbeck K. S., Caterson I. D. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up. Int J Obes Relat Metab Disord. 1995 Mar;19(3):181–189. [PubMed] [Google Scholar]
  74. Ohlson L. O., Larsson B., Svärdsudd K., Welin L., Eriksson H., Wilhelmsen L., Björntorp P., Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985 Oct;34(10):1055–1058. doi: 10.2337/diab.34.10.1055. [DOI] [PubMed] [Google Scholar]
  75. Ornish D., Brown S. E., Scherwitz L. W., Billings J. H., Armstrong W. T., Ports T. A., McLanahan S. M., Kirkeeide R. L., Brand R. J., Gould K. L. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990 Jul 21;336(8708):129–133. doi: 10.1016/0140-6736(90)91656-u. [DOI] [PubMed] [Google Scholar]
  76. Paffenbarger R. S., Jr, Kampert J. B., Chang H. G. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidemiol. 1980 Aug;112(2):258–268. doi: 10.1093/oxfordjournals.aje.a112992. [DOI] [PubMed] [Google Scholar]
  77. Pekkarinen T., Mustajoki P. Comparison of behavior therapy with and without very-low-energy diet in the treatment of morbid obesity. A 5-year outcome. Arch Intern Med. 1997 Jul 28;157(14):1581–1585. [PubMed] [Google Scholar]
  78. Pekkarinen T., Takala I., Mustajoki P. Two year maintenance of weight loss after a VLCD and behavioural therapy for obesity: correlation to the scores of questionnaires measuring eating behaviour. Int J Obes Relat Metab Disord. 1996 Apr;20(4):332–337. [PubMed] [Google Scholar]
  79. Phillips R. L., Snowdon D. A. Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst. 1985 Feb;74(2):307–317. [PubMed] [Google Scholar]
  80. Rabkin S. W., Chen Y., Leiter L., Liu L., Reeder B. A. Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group. CMAJ. 1997 Jul 1;157 (Suppl 1):S26–S31. [PubMed] [Google Scholar]
  81. Rabkin S. W., Mathewson F. A., Hsu P. H. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol. 1977 Mar;39(3):452–458. doi: 10.1016/s0002-9149(77)80104-5. [DOI] [PubMed] [Google Scholar]
  82. Reeder B. A., Angel A., Ledoux M., Rabkin S. W., Young T. K., Sweet L. E. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992 Jun 1;146(11):2009–2019. [PMC free article] [PubMed] [Google Scholar]
  83. Reeder B. A., Senthilselvan A., Després J. P., Angel A., Liu L., Wang H., Rabkin S. W. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ. 1997 Jul 1;157 (Suppl 1):S39–S45. [PubMed] [Google Scholar]
  84. Revicki D. A., Israel R. G. Relationship between body mass indices and measures of body adiposity. Am J Public Health. 1986 Aug;76(8):992–994. doi: 10.2105/ajph.76.8.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Ryttig K. R., Flaten H., Rössner S. Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination. Int J Obes Relat Metab Disord. 1997 Jul;21(7):574–579. doi: 10.1038/sj.ijo.0800444. [DOI] [PubMed] [Google Scholar]
  86. Saris W. H. The role of exercise in the dietary treatment of obesity. Int J Obes Relat Metab Disord. 1993 Feb;17 (Suppl 1):S17–S21. [PubMed] [Google Scholar]
  87. Sarlio-Lähteenkorva S., Stunkard A., Rissanen A. Psychosocial factors and quality of life in obesity. Int J Obes Relat Metab Disord. 1995 Nov;19 (Suppl 6):S1–S5. [PubMed] [Google Scholar]
  88. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  89. Skender M. L., Goodrick G. K., Del Junco D. J., Reeves R. S., Darnell L., Gotto A. M., Foreyt J. P. Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc. 1996 Apr;96(4):342–346. doi: 10.1016/S0002-8223(96)00096-X. [DOI] [PubMed] [Google Scholar]
  90. Smith P. L., Gold A. R., Meyers D. A., Haponik E. F., Bleecker E. R. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med. 1985 Dec;103(6 ):850–855. doi: 10.7326/0003-4819-103-6-850. [DOI] [PubMed] [Google Scholar]
  91. Smoller J. W., Wadden T. A., Stunkard A. J. Dieting and depression: a critical review. J Psychosom Res. 1987;31(4):429–440. doi: 10.1016/0022-3999(87)90001-8. [DOI] [PubMed] [Google Scholar]
  92. Snowdon D. A., Phillips R. L., Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol. 1984 Aug;120(2):244–250. doi: 10.1093/oxfordjournals.aje.a113886. [DOI] [PubMed] [Google Scholar]
  93. Stamler R., Stamler J., Grimm R., Gosch F. C., Elmer P., Dyer A., Berman R., Fishman J., Van Heel N., Civinelli J. Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. JAMA. 1987 Mar 20;257(11):1484–1491. doi: 10.1001/jama.257.11.1484. [DOI] [PubMed] [Google Scholar]
  94. Stamler R., Stamler J., Riedlinger W. F., Algera G., Roberts R. H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978 Oct 6;240(15):1607–1610. doi: 10.1001/jama.240.15.1607. [DOI] [PubMed] [Google Scholar]
  95. Stevens V. J., Corrigan S. A., Obarzanek E., Bernauer E., Cook N. R., Hebert P., Mattfeldt-Beman M., Oberman A., Sugars C., Dalcin A. T. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med. 1993 Apr 12;153(7):849–858. [PubMed] [Google Scholar]
  96. Stunkard A. J., Craighead L. W., O'Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980 Nov 15;2(8203):1045–1047. doi: 10.1016/s0140-6736(80)92272-2. [DOI] [PubMed] [Google Scholar]
  97. Suratt P. M., McTier R. F., Findley L. J., Pohl S. L., Wilhoit S. C. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest. 1987 Oct;92(4):631–637. doi: 10.1378/chest.92.4.631. [DOI] [PubMed] [Google Scholar]
  98. Sweeney M. E., Hill J. O., Heller P. A., Baney R., DiGirolamo M. Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss. Am J Clin Nutr. 1993 Feb;57(2):127–134. doi: 10.1093/ajcn/57.2.127. [DOI] [PubMed] [Google Scholar]
  99. Taylor C. B., Fortmann S. P., Flora J., Kayman S., Barrett D. C., Jatulis D., Farquhar J. W. Effect of long-term community health education on body mass index. The Stanford Five-City Project. Am J Epidemiol. 1991 Aug 1;134(3):235–249. doi: 10.1093/oxfordjournals.aje.a116077. [DOI] [PubMed] [Google Scholar]
  100. Torgerson J. S., Lissner L., Lindroos A. K., Kruijer H., Sjöström L. VLCD plus dietary and behavioural support versus support alone in the treatment of severe obesity. A randomised two-year clinical trial. Int J Obes Relat Metab Disord. 1997 Nov;21(11):987–994. doi: 10.1038/sj.ijo.0800507. [DOI] [PubMed] [Google Scholar]
  101. Tuck M. L., Sowers J., Dornfeld L., Kledzik G., Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 1981 Apr 16;304(16):930–933. doi: 10.1056/NEJM198104163041602. [DOI] [PubMed] [Google Scholar]
  102. Van Itallie T. B. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985 Dec;103(6 ):983–988. doi: 10.7326/0003-4819-103-6-983. [DOI] [PubMed] [Google Scholar]
  103. Waaler H. T. Height, weight and mortality. The Norwegian experience. Acta Med Scand Suppl. 1984;679:1–56. doi: 10.1111/j.0954-6820.1984.tb12901.x. [DOI] [PubMed] [Google Scholar]
  104. Wadden T. A., Stunkard A. J. Social and psychological consequences of obesity. Ann Intern Med. 1985 Dec;103(6 ):1062–1067. doi: 10.7326/0003-4819-103-6-1062. [DOI] [PubMed] [Google Scholar]
  105. Wardle J. Obesity and behaviour change: matching problems to practice. Int J Obes Relat Metab Disord. 1996 Feb;20 (Suppl 1):S1–S8. [PubMed] [Google Scholar]
  106. Weinsier R. L., James L. D., Darnell B. E., Dustan H. P., Birch R., Hunter G. R. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med. 1991 Apr;90(4):460–468. [PubMed] [Google Scholar]
  107. Weintraub M. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther. 1992 May;51(5):581–585. doi: 10.1038/clpt.1992.68. [DOI] [PubMed] [Google Scholar]
  108. Wilcosky T., Hyde J., Anderson J. J., Bangdiwala S., Duncan B. Obesity and mortality in the Lipid Research Clinics Program Follow-up Study. J Clin Epidemiol. 1990;43(8):743–752. doi: 10.1016/0895-4356(90)90232-e. [DOI] [PubMed] [Google Scholar]
  109. Willett W. C., Manson J. E., Stampfer M. J., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA. 1995 Feb 8;273(6):461–465. doi: 10.1001/jama.1995.03520300035033. [DOI] [PubMed] [Google Scholar]
  110. Williamson D. F., Pamuk E., Thun M., Flanders D., Byers T., Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995 Jun 15;141(12):1128–1141. doi: 10.1093/oxfordjournals.aje.a117386. [DOI] [PubMed] [Google Scholar]
  111. Wilson G. T. Relation of dieting and voluntary weight loss to psychological functioning and binge eating. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):727–730. doi: 10.7326/0003-4819-119-7_part_2-199310011-00020. [DOI] [PubMed] [Google Scholar]
  112. Wing R. R., Jeffery R. W. Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord. 1995 Jan;19(1):67–73. [PubMed] [Google Scholar]
  113. Wing R. R., Marcus M. D., Salata R., Epstein L. H., Miaskiewicz S., Blair E. H. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med. 1991 Jul;151(7):1334–1340. [PubMed] [Google Scholar]
  114. Wittels E. H., Thompson S. Obstructive sleep apnea and obesity. Otolaryngol Clin North Am. 1990 Aug;23(4):751–760. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES